Peptides get their regulatory closeup

An FDA advisory panel will meet this week to make recommendations on whether specialized pharmacies should be allowed to produce some popular wellness peptides. The meeting marks a regulatory focus on peptide production, which has grown in popularity for health and wellness purposes. The panel's recommendations could shape future FDA policy on these substances.